The reiteration of a Buy rating and a maintained price target of $15 by a reputable analyst firm like HC Wainwright & Co. is likely to instill confidence among investors and could lead to a positive short-term impact on Rigel Pharmaceuticals' stock price. Analyst ratings, especially with a Buy recommendation, often lead to increased investor interest and can drive stock prices up in the short term.